Speaker illustration

Professor Philippe L'Allier

Montreal Heart Institute, Montreal (Canada)

Dr Philippe L.-L'Allier, MD trained in internal medicine at the Université de Sherbrooke (Sherbrooke, Canada), in cardiology and interventional cardiology at the Université de Montréal (Montréal, Canada) and in advanced interventional cardiology/clinical research at the Cleveland Clinic (Cleveland, USA). He is affiliated with the Institut de Cardiologie de Montréal (Montréal, Canada) where he is an interventional and prevention cardiologist with specific interests in atherosclerosis. He holds a full professorship with the Université de Montréal (Faculty of Medicine). His specific areas of interest/expertise and research are invasive imaging/physiology, vascular inflammation, complex percutaneous coronary interventions and acute coronary syndromes.

Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Event: ESC Congress 2020

Topic: Inflammation

Session: Deep Dive in Acute Coronary Syndromes


ESC 365 is supported by